(Q57955493)

English

Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

based on heuristic

inferred from title

author name string

K Buchacz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

T Tong

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

A Greenberg

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

R K Baker

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

S D Holmberg

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

HIV Outpatient Study (HOPS) Investigators

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

451-456

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Renal safety of tenofovir in HIV treatment-experienced patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

A 12-month treatment with tenofovir does not impair bone mineral accrual in HIV-infected children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00407.X

21 January 2018

Identifiers

10.1111/J.1468-1293.2006.00407.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16925731%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57955493&oldid=1398211432"